These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37128907)

  • 1. Monoclonal antibodies for treatment of cold agglutinin disease.
    Gelbenegger G; Berentsen S; Jilma B
    Expert Opin Biol Ther; 2023 May; 23(5):395-406. PubMed ID: 37128907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Treatment Options in Cold Agglutinin Disease: B-Cell Directed or Complement Directed Therapy?
    Berentsen S; Tjønnfjord GE
    Transfus Med Rev; 2022 Oct; 36(4):181-187. PubMed ID: 36127205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-directed therapy for cold agglutinin disease: sutimlimab.
    Broome CM
    Expert Rev Hematol; 2023; 16(7):479-494. PubMed ID: 37256550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cold agglutinin disease.
    Berentsen S
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):226-231. PubMed ID: 27913484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease.
    Barcellini W; Fattizzo B
    Expert Rev Hematol; 2024 Jul; 17(7):287-294. PubMed ID: 38872338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sutimlimab for treatment of cold agglutinin disease: why, how and for whom?
    Berentsen S; Barcellini W; D'Sa S; Jilma B
    Immunotherapy; 2022 Oct; 14(15):1191-1204. PubMed ID: 35946351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates on the Diagnosis and Management of Cold Autoimmune Hemolytic Anemia.
    Gertz MA
    Hematol Oncol Clin North Am; 2022 Apr; 36(2):341-352. PubMed ID: 35282954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune hemolytic anemia.
    Hill A; Hill QA
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):382-389. PubMed ID: 30504336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cold AIHA and the best treatment strategies.
    Despotovic JM; Kim TO
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):90-95. PubMed ID: 36485161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program.
    Gelbenegger G; Schoergenhofer C; Derhaschnig U; Buchtele N; Sillaber C; Fillitz M; Schenk TM; D'Sa S; Cartwright R; Gilbert JC; Jilma B; Jaeger U
    Blood Adv; 2020 Mar; 4(6):997-1005. PubMed ID: 32176765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody based therapeutics for autoimmune hemolytic anemia.
    Cavallaro F; Barcellini W; Fattizzo B
    Expert Opin Biol Ther; 2023; 23(12):1227-1237. PubMed ID: 37874225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cold agglutinin-mediated autoimmune hemolytic anemia.
    Berentsen S; Randen U; Tjønnfjord GE
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):455-71. PubMed ID: 26043385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment strategies of autoimmune hemolytic anemia].
    Yue WR; Wu T; Wang XQ
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jun; 45(6):615-620. PubMed ID: 39134500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sutimlimab: A Complement C1s Inhibitor for the Management of Cold Agglutinin Disease-Associated Hemolysis.
    Moore DC; Arnall JR
    Ann Pharmacother; 2023 Aug; 57(8):970-977. PubMed ID: 36476151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial.
    Jäger U; D'Sa S; Schörgenhofer C; Bartko J; Derhaschnig U; Sillaber C; Jilma-Stohlawetz P; Fillitz M; Schenk T; Patou G; Panicker S; Parry GC; Gilbert JC; Jilma B
    Blood; 2019 Feb; 133(9):893-901. PubMed ID: 30559259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging treatment options for autoimmune hemolytic anemia.
    Barcellini W; Fattizzo B; Zaninoni A
    Expert Rev Clin Immunol; 2018 Oct; 14(10):857-872. PubMed ID: 30204521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cold agglutinin disease: pathology, diagnosis, and treatment].
    Wada H
    Rinsho Ketsueki; 2024; 65(6):521-528. PubMed ID: 38960651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoimmune hemolytic anemia].
    Čermák J; Písačka M
    Vnitr Lek; 2018; 64(5):514-519. PubMed ID: 30193520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease.
    Zaninoni A; Giannotta JA; Gallì A; Artuso R; Bianchi P; Malcovati L; Barcellini W; Fattizzo B
    Front Immunol; 2021; 12():649441. PubMed ID: 33732266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory cold agglutinin disease successfully treated with daratumumab. A case report and review of literature.
    Mohamed A; Alkhatib M; Alshurafa A; El Omri H
    Hematology; 2023 Dec; 28(1):2252651. PubMed ID: 37664905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.